SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Veronica Francardo, Hanna Iderberg, Hanna Lindgren, M. Angela Cenci, Movement Disorders, 2015,

    CrossRef

  2. 2
    Mark Wade, Thomas J. Hoffmann, Jennifer M. Jenkins, Association between the arginine vasopressin receptor 1A (AVPR1A) gene and preschoolers’ executive functioning, Brain and Cognition, 2014, 90, 116

    CrossRef

  3. 3
    Jin Yong Hong, Hyuk Jin Yun, Mun Kyung Sunwoo, Jee Hyun Ham, Jong-Min Lee, Young H. Sohn, Phil Hyu Lee, Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 9, 999

    CrossRef

  4. 4
    Trevor W. Robbins, Roshan Cools, Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective, Movement Disorders, 2014, 29, 5
  5. 5
    Paraskevi Kourtidou, Dimitrios Kasselimis, Constantin Potagas, Ioannis Zalonis, Ioannis Evdokimidis, Dissociation Between the Effects of Mental Flexibility and Motor Dysfunction on Cognitive Performance in Patients With Parkinson's Disease, Archives of Neuroscience, 2014, 2, 3

    CrossRef

  6. 6
    Alaina Borden, David Wallon, Romain Lefaucheur, Stéphane Derrey, Damien Fetter, Marc Verin, David Maltête, Does early verbal fluency decline after STN implantation predict long-term cognitive outcome after STN-DBS in Parkinson's disease?, Journal of the Neurological Sciences, 2014, 346, 1-2, 299

    CrossRef

  7. 7
    J. E. Lee, K. H. Cho, S. K. Song, H. J. Kim, H. S. Lee, Y. H. Sohn, P. H. Lee, Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 1, 7

    CrossRef

  8. 8
    Lucía-Azahara Rodríguez, Salvador Algarabel, Joaquín Escudero, Exploring recollection and familiarity impairments in Parkinson’s disease, Journal of Clinical and Experimental Neuropsychology, 2014, 36, 5, 494

    CrossRef

  9. 9
    Young-Eun C. Lee, David R. Williams, Jacqueline F. I. Anderson, Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease, Journal of Neuropsychology, 2014, 8, 2
  10. 10
    Sarah F. Moore, Roger A. Barker, Predictors of Parkinson's disease dementia: Towards targeted therapies for a heterogeneous disease, Parkinsonism & Related Disorders, 2014, 20, S104

    CrossRef

  11. 11
    M. K. Sunwoo, S. Jeon, J. H. Ham, J. Y. Hong, J. E. Lee, J.-M. Lee, Y. H. Sohn, P. H. Lee, The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease, European Journal of Neurology, 2014, 21, 6
  12. 12
    Joanne E. Wittwer, Kate E. Webster, Keith Hill, The effects of a concurrent motor task on walking in Alzheimer's disease, Gait & Posture, 2014, 39, 1, 291

    CrossRef

  13. 13
    Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda, James E. Galvin, The spectrum of cognitive impairment in Lewy body diseases, Movement Disorders, 2014, 29, 5
  14. 14
    Pietro Cipresso, Giovanni Albani, Silvia Serino, Elisa Pedroli, Federica Pallavicini, Alessandro Mauro, Giuseppe Riva, Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson’s disease, Frontiers in Behavioral Neuroscience, 2014, 8,

    CrossRef

  15. 15
    Audrey McKinlay, A review of cognitive and other non-motor problems in Parkinson’s disease, Aging Health, 2013, 9, 1, 89

    CrossRef

  16. 16
    Georg Dirnberger, Marjan Jahanshahi, Executive dysfunction in Parkinson's disease: A review, Journal of Neuropsychology, 2013, 7, 2
  17. 17
    Rachel G. Gross, Emily Camp, Corey T. McMillan, Michael Dreyfuss, Delani Gunawardena, Philip A. Cook, Brianna Morgan, Andrew Siderowf, Howard I. Hurtig, Matthew B. Stern, Murray Grossman, Impairment of script comprehension in Lewy body spectrum disorders, Brain and Language, 2013, 125, 3, 330

    CrossRef

  18. 18
    Carolina de Oliveira Souza, Mariana Callil Voos, Débora Valente Francato, Hsin Fen Chien, Egberto Reis Barbosa, Influence of Educational Status on Executive Function and Functional Balance in Individuals with Parkinson Disease, Cognitive And Behavioral Neurology, 2013, 26, 1, 6

    CrossRef

  19. 19
    David J. Irwin, Virginia M.-Y. Lee, John Q. Trojanowski, Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies, Nature Reviews Neuroscience, 2013, 14, 9, 626

    CrossRef

  20. 20
    Joana B. Pereira, Carme Junqué, David Bartrés-Faz, Blanca Ramírez-Ruiz, Maria-Jose Marti, Eduardo Tolosa, Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease, Hippocampus, 2013, 23, 8
  21. 21
    S. Cavaco, A. Goncalves, C. Pinto, E. Almeida, F. Gomes, I. Moreira, J. Fernandes, A. Teixeira-Pinto, Semantic Fluency and Phonemic Fluency: Regression-based Norms for the Portuguese Population, Archives of Clinical Neuropsychology, 2013, 28, 3, 262

    CrossRef

  22. 22
    Julie A. Fields, Alexander I. Tröster, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  23. 23
    Julie Fields, Alexander Tröster, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  24. 24
    Neil Archibald, Nick Miller, Lynn Rochester, Neurological Rehabilitation, 2013,

    CrossRef

  25. 25
    D. Weintraub, N. Dietz, J. E. Duda, D. A. Wolk, J. Doshi, S. X. Xie, C. Davatzikos, C. M. Clark, A. Siderowf, Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease, Brain, 2012, 135, 1, 170

    CrossRef

  26. 26
    Sarah L. Mason, Roger A. Barker, Cognitive Deficits in Early Parkinson’s Disease: New Areas of Research, Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1, 1, 39

    CrossRef

  27. 27
    Hanna S. Lindgren, Stephen B. Dunnett, Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?, European Journal of Neuroscience, 2012, 35, 12
  28. 28
    J.H. Liu, X.S. Li, J. Ye, L.H. Gao, Z.P. Zhang, W. Wu, L. Yao, J. Zhang, Cognitive impairments in Parkinson's disease, Aging & Mental Health, 2012, 16, 4, 529

    CrossRef

  29. 29
    Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben A. Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C. Rodriguez-Oroz, David J. Burn, Roger A. Barker, Murat Emre, Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines, Movement Disorders, 2012, 27, 3
  30. 30
    C.A. Brown, M.C. Campbell, M. Karimi, S.D. Tabbal, S.K. Loftin, L.L. Tian, S.M. Moerlein, J.S. Perlmutter, Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys, Experimental Neurology, 2012, 236, 1, 190

    CrossRef

  31. 31
    I. P. Miah, K. T. Olde Dubbelink, D. Stoffers, J. B. Deijen, H. W. Berendse, Early-stage cognitive impairment in Parkinson’s disease and the influence of dopamine replacement therapy, European Journal of Neurology, 2012, 19, 3
  32. 32
    Maria I. Ventura, Kathleen Baynes, Karen A. Sigvardt, April M. Unruh, Sarah S. Acklin, Heidi E. Kirsch, Elizabeth A. Disbrow, Hemispheric asymmetries and prosodic emotion recognition deficits in Parkinson's disease, Neuropsychologia, 2012, 50, 8, 1936

    CrossRef

  33. 33
    Jin Yong Hong, Ji Eun Lee, Young H. Sohn, Phil Hyu Lee, Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints, Journal of Neurology, 2012, 259, 8, 1706

    CrossRef

  34. 34
    David Garcia-Garcia, Pedro Clavero, Carmen Gasca Salas, Isabel Lamet, Javier Arbizu, Rafael Gonzalez-Redondo, Jose A. Obeso, Maria C. Rodriguez-Oroz, Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 11, 1767

    CrossRef

  35. 35
    Nicola J. Ray, Antonio P. Strafella, The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging, Movement Disorders, 2012, 27, 12
  36. 36
    Elena Herrera, Fernando Cuetos, Renée Ribacoba, Verbal fluency in Parkinson’s disease patients on/off dopamine medication, Neuropsychologia, 2012, 50, 14, 3636

    CrossRef

  37. 37
    Dario Arnaldi, Claudio Campus, Michela Ferrara, Francesco Famà, Agnese Picco, Fabrizio De Carli, Jennifer Accardo, Andrea Brugnolo, Gianmario Sambuceti, Silvia Morbelli, Flavio Nobili, What predicts cognitive decline in de novo Parkinson's disease?, Neurobiology of Aging, 2012, 33, 6, 1127.e11

    CrossRef

  38. 38
    Audrey McKinlay, Randolph C. Grace, Characteristic of Cognitive Decline in Parkinson's Disease: A 1-Year Follow-Up, Applied Neuropsychology, 2011, 18, 4, 269

    CrossRef

  39. 39
    John C. Dalrymple-Alford, Leslie Livingston, Michael R. MacAskill, Charlotte Graham, Tracy R. Melzer, Richard J. Porter, Richard Watts, Tim J. Anderson, Characterizing mild cognitive impairment in Parkinson's disease, Movement Disorders, 2011, 26, 4
  40. 40
    Paolo Barone, Dag Aarsland, David Burn, Murat Emre, Jaime Kulisevsky, Daniel Weintraub, Cognitive impairment in nondemented Parkinson's disease, Movement Disorders, 2011, 26, 14
  41. 41
    A. Yu. Yablonskaya, N. V. Fedorova, M. E. Belgusheva, Effects of Amantadine Sulfate on Cognitive Impairments in Patients with Parkinson’s Disease, Neuroscience and Behavioral Physiology, 2011, 41, 6, 567

    CrossRef

  42. 42
    Michele Poletti, Murat Emre, Ubaldo Bonuccelli, Mild cognitive impairment and cognitive reserve in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 8, 579

    CrossRef

  43. 43
    David P. Breen, Andrew W. Michell, Roger A. Barker, Parkinson's disease – the continuing search for biomarkers, Clinical Chemistry and Laboratory Medicine, 2011, 49, 3

    CrossRef

  44. 44
    John N. Caviness, LihFen Lue, Charles H. Adler, Douglas G. Walker, Parkinson's Disease Dementia and Potential Therapeutic Strategies, CNS Neuroscience & Therapeutics, 2011, 17, 1
  45. 45
    Alice S. Chen-Plotkin, William T. Hu, Andrew Siderowf, Daniel Weintraub, Rachel Goldmann Gross, Howard I. Hurtig, Sharon X. Xie, Steven E. Arnold, Murray Grossman, Christopher M. Clark, Leslie M. Shaw, Leo McCluskey, Lauren Elman, Vivianna M. Van Deerlin, Virginia M.-Y. Lee, Holly Soares, John Q. Trojanowski, Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease, Annals of Neurology, 2011, 69, 4
  46. 46
    Hasmet A. Hanagasi, Hakan Gurvit, Pınar Unsalan, Hilal Horozoglu, Nese Tuncer, Aynur Feyzioglu, Dilek Ince Gunal, Gorsev G. Yener, Raif Cakmur, Huseyin A. Sahin, Murat Emre, The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study, Movement Disorders, 2011, 26, 10
  47. 47
    Alison Yarnall, Lynn Rochester, David J. Burn, The interplay of cholinergic function, attention, and falls in Parkinson's disease, Movement Disorders, 2011, 26, 14
  48. 48
    R. García-Ramos, C. Villanueva, J. del Val, J. Matías-Guíu, Apathy in Parkinson's disease, Neurología (English Edition), 2010, 25, 1, 40

    CrossRef

  49. 49
    R. García-Ramos, C. Villanueva, J. del Val, J. Matías-Guíu, Apatía en la enfermedad de Parkinson, Neurología, 2010, 25, 1, 40

    CrossRef

  50. 50
    Javier Rodríguez-Ferreiro, Fernando Cuetos, Elena Herrera, Manuel Menéndez, Renée Ribacoba, Cognitive impairment in Parkinson's disease without dementia, Movement Disorders, 2010, 25, 13
  51. 51
    D. A. Stepkina, V. V. Zakharov, N. N. Yakhno, Cognitive Impairments in Progression of Parkinson’s Disease, Neuroscience and Behavioral Physiology, 2010, 40, 1, 61

    CrossRef

  52. 52
    Y. Nishio, K. Hirayama, A. Takeda, Y. Hosokai, T. Ishioka, K. Suzuki, Y. Itoyama, S. Takahashi, E. Mori, Corticolimbic gray matter loss in Parkinson’s disease without dementia, European Journal of Neurology, 2010, 17, 8
  53. 53
    Angie A Kehagia, Roger A Barker, Trevor W Robbins, Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease, The Lancet Neurology, 2010, 9, 12, 1200

    CrossRef

  54. 54
    Dag Aarsland, Martin Wilhelm Kurz, The epidemiology of dementia associated with Parkinson disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 18

    CrossRef

  55. 55
    Dag Aarsland, Martin Wilhelm Kurz, The Epidemiology of Dementia Associated with Parkinson's Disease, Brain Pathology, 2010, 20, 3
  56. 56
    Matthias Löhle, Alexander Storch, Heinz Reichmann, Beyond tremor and rigidity: non-motor features of Parkinson’s disease, Journal of Neural Transmission, 2009, 116, 11, 1483

    CrossRef

  57. 57
    Yaroslau Compta, María J. Martí, Naroa Ibarretxe-Bilbao, Carme Junqué, Francesc Valldeoriola, Esteban Muñoz, Mario Ezquerra, Jose Ríos, Eduardo Tolosa, Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease, Movement Disorders, 2009, 24, 15
  58. 58
    Yoshiyuki Hosokai, Yoshiyuki Nishio, Kazumi Hirayama, Atsushi Takeda, Toshiyuki Ishioka, Yoichi Sawada, Kyoko Suzuki, Yasuto Itoyama, Shoki Takahashi, Hiroshi Fukuda, Etsuro Mori, Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment, Movement Disorders, 2009, 24, 6
  59. 59
    Sarra Nazem, Andrew D. Siderowf, John E. Duda, Tom Ten Have, Amy Colcher, Stacy S. Horn, Paul J. Moberg, Jayne R. Wilkinson, Howard I. Hurtig, Matthew B. Stern, Daniel Weintraub, Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with “Normal” Global Cognition According to Mini-Mental State Examination Score, Journal of the American Geriatrics Society, 2009, 57, 2
  60. 60
    Heinz Reichmann, Christine Schneider, Matthias Löhle, Non-motor features of Parkinson's disease: depression and dementia, Parkinsonism & Related Disorders, 2009, 15, S87

    CrossRef

  61. 61
    C. Vossius, O. B. Nilsen, J. P. Larsen, Parkinson’s disease and nursing home placement: the economic impact of the need for care, European Journal of Neurology, 2009, 16, 2
  62. 62
    T. J. O'Brien, V. Wadley, A. P. Nicholas, N. P. Stover, R. Watts, H. R. Griffith, The Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease, Archives of Clinical Neuropsychology, 2009, 24, 3, 237

    CrossRef

  63. 63
    N. K. Archibald, M. P. Clarke, U. P. Mosimann, D. J. Burn, The retina in Parkinson's disease, Brain, 2009, 132, 5, 1128

    CrossRef

  64. 64
    Bradley J. Robottom, William J. Weiner, Neurobiology of Dementia, 2009,

    CrossRef

  65. 65
    Thomas P. Bouchard, Nikolai Malykhin, W.R. Wayne Martin, Christopher C. Hanstock, Derek J. Emery, Nancy J. Fisher, Richard M. Camicioli, Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease, Neurobiology of Aging, 2008, 29, 7, 1027

    CrossRef

  66. 66
    In-Uk Song, Joong-Seok Kim, Ji-Yeon Yoo, Hyun-Joo Song, Kwang-Soo Lee, Cognitive Dysfunctions in Mild Parkinson’s Disease Dementia: Comparison with Patients Having Mild Alzheimer’s Disease and Normal Controls, European Neurology, 2008, 59, 1-2, 49

    CrossRef

  67. 67
    In-Uk Song, Joong-Seok Kim, Du-Shin Jeong, Hyun-Joo Song, Kwang-Soo Lee, Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia, Parkinsonism & Related Disorders, 2008, 14, 7, 558

    CrossRef

  68. 68
    K. Imamura, K. Wada-Isoe, M. Kitayama, K. Nakashima, Executive dysfunction in non-demented Parkinson’s disease patients with hallucinations, Acta Neurologica Scandinavica, 2008, 117, 4
  69. 69
    Gabriella Santangelo, Luigi Trojano, Carmine Vitale, Marta Ianniciello, Marianna Amboni, Dario Grossi, Paolo Barone, A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations, Movement Disorders, 2007, 22, 16
  70. 70
    Blanca Ramirez-Ruiz, Carme Junque, Maria-Jose Marti, Francesc Valldeoriola, Eduardo Tolosa, Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations, Dementia and Geriatric Cognitive Disorders, 2007, 23, 5, 281

    CrossRef

  71. 71
    Nuria Caballol, Maria J Martí, Eduardo Tolosa, Cognitive dysfunction and dementia in Parkinson disease, Movement Disorders, 2007, 22, S17
  72. 72
    John N. Caviness, Erika Driver-Dunckley, Donald J. Connor, Marwan N. Sabbagh, Joseph G. Hentz, Brie Noble, Virgilio Gerald H. Evidente, Holly A. Shill, Charles H. Adler, Defining mild cognitive impairment in Parkinson's disease, Movement Disorders, 2007, 22, 9
  73. 73
    Maria J. Martí, Eduardo Tolosa, Andres de la Cerda, Dementia in Parkinson's disease, Journal of Neurology, 2007, 254, S5, 41

    CrossRef

  74. You have free access to this content74
    Bruno Dubois, David Burn, Christopher Goetz, Dag Aarsland, Richard G. Brown, Gerald A. Broe, Dennis Dickson, Charles Duyckaerts, Jefferey Cummings, Serge Gauthier, Amos Korczyn, Andrew Lees, Richard Levy, Irene Litvan, Yoshikuni Mizuno, Ian G. McKeith, C. Warren Olanow, Werner Poewe, Cristina Sampaio, Eduardo Tolosa, Murat Emre, Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force, Movement Disorders, 2007, 22, 16
  75. 75
    Oren S. Cohen, Eli Vakil, David Tanne, Zeev Nitsan, Roseline Schwartz, Sharon Hassin-Baer, Educational Level as a Modulator of Cognitive Performance and Neuropsychyatric Features in Parkinson Disease, Cognitive and Behavioral Neurology, 2007, 20, 1, 68

    CrossRef

  76. 76
    Stijn Verleden, Guy Vingerhoets, Patrick Santens, Heterogeneity of Cognitive Dysfunction in Parkinson’s Disease: A Cohort Study, European Neurology, 2007, 58, 1, 34

    CrossRef

  77. 77
    Maja Relja, Nataša Klepac, A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease, Journal of the Neurological Sciences, 2006, 248, 1-2, 251

    CrossRef

  78. 78
    James E. Galvin, Cognitive Change in Parkinson Disease, Alzheimer Disease & Associated Disorders, 2006, 20, 4, 302

    CrossRef

  79. 79
    Elena Moro, Anthony E Lang, Criteria for deep-brain stimulation in Parkinson’s disease: review and analysis, Expert Review of Neurotherapeutics, 2006, 6, 11, 1695

    CrossRef

  80. 80
    Anthony E. Lang, Jean-Luc Houeto, Paul Krack, Cynthia Kubu, Kelly E. Lyons, Elena Moro, William Ondo, Rajesh Pahwa, Werner Poewe, Alexander I. Tröster, Ryan Uitti, Valerie Voon, Deep brain stimulation: Preoperative issues, Movement Disorders, 2006, 21, S14
  81. 81
    Arvid Rongve, Dag Aarsland, Management of Parkinson???s Disease Dementia, Drugs & Aging, 2006, 23, 10, 807

    CrossRef

  82. 82
    Liesl M. Allcock, Rose Anne Kenny, Urs Peter Mosimann, Sherley Tordoff, Keith A. Wesnes, Anthony J. Hildreth, David J. Burn, Orthostatic hypotension in Parkinson's disease: association with cognitive decline?, International Journal of Geriatric Psychiatry, 2006, 21, 8
  83. 83
    M. W. Riepe, J. Kassubek, F. Tracik, G. Ebersbach, Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?, Journal of Neural Transmission, 2006, 113, 10, 1463

    CrossRef

  84. 84
    Carmen Cristea Janvin, Jan Petter Larsen, Dag Aarsland, Kenneth Hugdahl, Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia, Movement Disorders, 2006, 21, 9
  85. 85
    Julie G. Pilitsis, Ali R. Rezai, Nicholas M. Boulis, Jaimie M. Henderson, Robyn M. Busch, Cynthia S. Kubu, A Preliminary Study of Transient Confusional States following Bilateral Subthalamic Stimulation for Parkinson’s Disease, Stereotactic and Functional Neurosurgery, 2005, 83, 2-3, 67

    CrossRef

  86. 86
    B. Ramírez–Ruiz, M. J. Martí, E. Tolosa, D. Bartrés–Faz, Ch. Summerfield, P. Salgado–Pineda, B. Gómez–Ansón, C. Junqué, Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia, Journal of Neurology, 2005, 252, 11, 1345

    CrossRef

  87. 87
    Daniel Weintraub, Matthew B. Stern, Psychiatric Complications in Parkinson Disease, The American Journal of Geriatric Psychiatry, 2005, 13, 10, 844

    CrossRef

  88. 88
    Dag Aarsland, Carmen Janvin, Dementia 3Ed, 2005,

    CrossRef

  89. 89
    Carol Manning, Beyond memory: neuropsychologic features in differential diagnosis of dementia, Clinics in Geriatric Medicine, 2004, 20, 1, 45

    CrossRef

  90. 90
    Kathy Dujardin, Luc Defebvre, Alain Duhamel, Pascal Lecouffe, Pascal Rogelet, Marc Steinling, Alain Dest�e, Cognitive and SPECT characteristics predict progression of Parkinson?s disease in newly diagnosed patients, Journal of Neurology, 2004, 251, 11, 1383

    CrossRef

  91. 91
    Richard Camicioli, Nancy Fisher, Progress in Clinical Neurosciences: Parkinson's Disease with Dementia and Dementia with Lewy Bodies, The Canadian Journal of Neurological Sciences, 2004, 31, 01, 7

    CrossRef

  92. 92
    Current Awareness in Geriatric Psychiatry, International Journal of Geriatric Psychiatry, 2003, 18, 4
  93. 93
    Robert A. Stern, Stacy L. Andersen, Brandon E. Gavett, Executive Functioning,
  94. 94
    Leonardo Cruz de Souza, Virginie Czernecki, Bruno Dubois, Neuropsychologic Features of Parkinson's Dementias,